Pyridoxamine Phosphate.

Pyridoxamine 5-phosphate is oxidised to pyridoxal 5-phosphate, the form that enzymes actually use as a cofactor. The two sit one step apart in the same B6 pool.

The oxidase that converts pyridoxamine 5-phosphate into pyridoxal 5-phosphate is FMN dependent, and FMN comes from riboflavin. Low riboflavin status slows that conversion step.

Riboflavin is phosphorylated to FMN, the cofactor pyridoxine 5-phosphate oxidase needs to hand B6 into its active form. The two vitamins are linked at that single enzymatic step.

Pyridoxal kinase phosphorylates B6 vitamers using ATP held by magnesium. Magnesium status therefore sits upstream of how much phosphorylated B6 the body can hold.

Pyridoxal kinase is a zinc-containing enzyme, so zinc availability affects the salvage of B6 vitamers into their phosphorylated forms. The pairing is a straightforward cofactor dependency.

Pyridoxine and pyridoxamine enter the same salvage enzymes and converge on pyridoxal 5-phosphate. Supplying both does not add a second pathway, it loads one pool from two entry points.

Folate carries the methyl group that remethylates homocysteine while B6 drives the transsulfuration branch that disposes of it. The two cover different exits from the same junction.

B12 is the cofactor for methionine synthase and B6 for the cystathionine enzymes downstream. Together with folate they form the classic three-cofactor set for homocysteine handling.

Betaine remethylates homocysteine through a B6-independent enzyme, while B6 clears it down the transsulfuration branch. The two routes work on the same substrate from different sides.

Both cystathionine beta-synthase and cystathionine gamma-lyase are pyridoxal 5-phosphate enzymes, and their output is cysteine. B6 status sets how much cysteine the body can make from methionine.

Cysteine sulfinic acid decarboxylase, the step that produces taurine from cysteine, is pyridoxal 5-phosphate dependent. Endogenous taurine synthesis tracks B6 availability.

Serine hydroxymethyltransferase and the glycine cleavage system are both pyridoxal 5-phosphate enzymes. B6 governs how glycine is made and how it is broken down.

Serine and glycine interconvert through the pyridoxal 5-phosphate enzyme serine hydroxymethyltransferase. That single step also loads the folate one-carbon pool.

Kynureninase, a step in tryptophan breakdown, is pyridoxal 5-phosphate dependent. When B6 is low, tryptophan metabolites shunt away from the usual route.

The conversion of tryptophan into niacin runs through the PLP-dependent kynureninase step. B6 status therefore affects how much niacin the body makes for itself.

Aromatic L-amino acid decarboxylase converts 5-HTP into serotonin using pyridoxal 5-phosphate. Adding B6 changes where and how fast that decarboxylation happens.

Glutamate decarboxylase, which forms GABA from glutamate, is a pyridoxal 5-phosphate enzyme. B6 availability is a direct input to endogenous GABA formation.

Glutamate is both the substrate for the PLP-dependent decarboxylase that yields GABA and the amino donor in PLP-dependent transaminations. B6 sits on both of those reactions.

Histidine decarboxylase is pyridoxal 5-phosphate dependent, so B6 status shapes how histidine is decarboxylated. The pairing is a plain cofactor and substrate relationship.

Delta-aminolevulinate synthase, the first committed step of haem building, is a pyridoxal 5-phosphate enzyme, and the porphyrin it starts then incorporates iron. B6 supply and iron supply meet at that chain.

Pyridoxal 5-phosphate is the cofactor of the decarboxylase that converts L-dopa to dopamine outside the brain. Extra B6 alongside an L-dopa source pushes more of that conversion to happen peripherally, leaving less to cross into the brain.

Pyridoxamine binds reactive carbonyl intermediates formed when sugars react with proteins, and benfotiamine diverts the upstream triose phosphates that feed those intermediates. The two act at different points of the same carbonyl route.

Carnosine and pyridoxamine both carry a nucleophilic amine that attaches to reactive carbonyl species. Formulators pair them because they scavenge overlapping intermediates.

Cystathionine beta-synthase and cystathionine gamma-lyase, the two enzymes that carry homocysteine down the transsulfuration route to cysteine, both require pyridoxal 5'-phosphate. Pyridoxamine 5'-phosphate is the vitamer that interconverts with pyridoxal 5'-phosphate through PNPO, so B6 status governs how fast methionine-derived homocysteine is cleared this way. Without adequate B6 the route slows regardless of methionine supply.

Aromatic L-amino acid decarboxylase, which converts L-DOPA to dopamine, is a pyridoxal 5'-phosphate enzyme. Tyrosine supplies the substrate at the top of that chain and the B6 vitamer supplies the cofactor for the decarboxylation step. Substrate without cofactor does not move through the pathway.

Ornithine aminotransferase and ornithine decarboxylase both depend on pyridoxal 5'-phosphate, the vitamer that pyridoxamine phosphate converts into. That places B6 at the junction between the urea cycle and polyamine synthesis. The relationship is enzymology rather than a measured supplement combination.

Branched-chain aminotransferase, the first step in leucine catabolism, is a pyridoxal 5'-phosphate enzyme, and it is precisely during transamination that the cofactor cycles between its pyridoxal and pyridoxamine forms. Pyridoxamine phosphate is therefore not a bystander in this reaction, it is the amino-carrying half of the catalytic cycle. B6 supply sets how fast branched-chain amino acids can be transaminated.

Once glutamine is deamidated to glutamate, the transaminases that move that amino group onward run on pyridoxal 5'-phosphate. The cofactor alternates between its pyridoxal and pyridoxamine phosphate forms with each amino group transferred. This is standard transaminase chemistry.

Both pyridoxamine and lipoic acid are described as trapping reactive carbonyl species, the intermediates that go on to form advanced glycation end products. They act by different chemistry, one through its free amino group and one through its dithiolane ring. The convergence is mechanistic and the readouts in the literature are markers.

N-acetylcysteine's thiol traps reactive carbonyls and it also supplies cysteine for glutathione. Pyridoxamine's free amino group traps the same class of dicarbonyl intermediates by a different route, and B6 is separately the cofactor for making cysteine from homocysteine. The two touch the same chemistry from different sides.

S-adenosylmethionine donates a methyl group and leaves homocysteine behind, which is then either remethylated using folate and B12 or cleared through the B6-dependent transsulfuration route. Adequate B6 vitamer supply is what keeps the second route open. Taking a methyl donor without the cofactors that clear its product loads one arm of the pathway.

Arginine sits in the urea cycle immediately alongside ornithine, whose aminotransferase is a pyridoxal 5'-phosphate enzyme. B6 status therefore shapes how nitrogen moves through that cycle. The relationship is pathway adjacency, not a tested pairing.

Choline oxidised to betaine remethylates homocysteine back to methionine, while B6 vitamers drive the alternative route that disposes of homocysteine as cysteine. The two cover different exits from the same intermediate. Formulas that carry both are covering both arms of one-carbon metabolism.